In our results, the OR of the association with CDKN2A methylation for the EAC subgroup was greater than that for the ESCC subgroup, indicating that this molecular feature may be more relevant in EAC. The gene discussed is CDKN2A; the disease is esophageal squamous cell carcinoma.